Biohaven Pharmaceutical Holding Company Ltd

NYSE:BHVN  
91.55
+1.93 (+2.15%)
Other Pre-Announcement

Biohaven Reports Q3 Loss Per Share Of $3.27

Published: 11/09/2020 14:30 GMT
Biohaven Pharmaceutical Holding Company Ltd (BHVN) - Biohaven Reports Third Quarter 2020 Financial Results and Recent Business Developments.
Q3 Adjusted Non-GAAP Loss per Share $2.67.
Q3 Earnings per Share Estimate $-2.89 -- Refinitiv Ibes Data (analyst estimates).
Q3 Loss per Share $3.27.
Q3 Revenue $17.7 Million Versus Refinitiv Ibes Estimate of $19.3 Million.